Preoperative Chemotherapy for Bladder Cancer
作者： Guru Sonpavde , Shahrokh F. Shariat
DOI: 10.1002/CNCR.26239
关键词:
摘要: Surprisingly, a higher proportion of patients(22%) received AC. A mere 9% all patients cisplatin-based NC. Althoughthe reasons for this practice patternareunclear,renaldysfunction, poorperformancestatus,comorbidities,andagemayberesponsible.Moreover,datadem-onstrate the high prevalence renal dysfunction in perioperative setting, and probability dysfunctionincreaseswithageto>40%ofpatientsaged>70years.
sci-hub.se 参考文章(18)
Guru Sonpavde, Myrna M. Khan, Robert S. Svatek, Richard Lee, Giacomo Novara, Derya Tilki, Seth P. Lerner, Gilad E. Amiel, Eila Skinner, Pierre I. Karakiewicz, Patrick J. Bastian, Wassim Kassouf, Hans-Martin Fritsche, Jonathan I. Izawa, Vincenzo Ficarra, Colin P. Dinney, Yair Lotan, Yves Fradet, Shahrokh F. Shariat, Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy BJU International. ,vol. 108, pp. no- no ,(2010) , 10.1111/J.1464-410X.2010.09902.X
Emil Scosyrev, Edward M. Messing, Edwin van Wijngaarden, Derick R. Peterson, Deepak Sahasrabudhe, Dragan Golijanin, Susan G. Fisher, Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. Cancer. ,vol. 118, pp. 72- 81 ,(2012) , 10.1002/CNCR.26238
Paul D. Williams, Sooyoung Cheon, Dmytro M. Havaleshko, Hyeon Jeong, Feng Cheng, Dan Theodorescu, Jae K. Lee, Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy. Cancer Research. ,vol. 69, pp. 8302- 8309 ,(2009) , 10.1158/0008-5472.CAN-09-0798
S. Machele Donat, Ahmad Shabsigh, Caroline Savage, Angel M. Cronin, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, Matthew I. Milowsky, Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience European Urology. ,vol. 55, pp. 177- 186 ,(2009) , 10.1016/J.EURURO.2008.07.018
H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V.O. Speights, Nicholas J. Vogelzang, Donald L. Trump, Ralph W. deVere White, Michael F. Sarosdy, David P. Wood, Derek Raghavan, E. David Crawford, Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer The New England Journal of Medicine. ,vol. 349, pp. 859- 866 ,(2003) , 10.1056/NEJMOA022148
Wassim Kassouf, Piyush K. Agarwal, H. Barton Grossman, Dan Leibovici, Mark F. Munsell, Arlene Siefker-Radtke, Louis L. Pisters, David A. Swanson, Colin P.N. Dinney, Ashish M. Kamat, Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology. ,vol. 73, pp. 147- 152 ,(2009) , 10.1016/J.UROLOGY.2008.07.035
Guru Sonpavde, Myrna M. Khan, Seth P. Lerner, Robert S. Svatek, Giacomo Novara, Pierre I. Karakiewicz, Eila Skinner, Derya Tilki, Wassim Kassouf, Yves Fradet, Colin P. Dinney, Hans-Martin Fritsche, Jonathan I. Izawa, Patrick J. Bastian, Vincenzo Ficarra, Mark Schoenberg, Arthur I. Sagalowsky, Yair Lotan, Shahrokh F. Shariat, Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer The Journal of Urology. ,vol. 185, pp. 456- 461 ,(2011) , 10.1016/J.JURO.2010.09.110
S A Hussain, D D Stocken, P Riley, D H Palmer, D R Peake, J I Geh, D Spooner, N D James, A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. British Journal of Cancer. ,vol. 91, pp. 844- 849 ,(2004) , 10.1038/SJ.BJC.6602112
Ralph W. deVere White, Primo N. Lara, Bryan Goldman, Cathy M. Tangen, David C. Smith, David P. Wood, Maha H.A. Hussain, E. David Crawford, A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219) Journal of Urology. ,vol. 181, pp. 2476- 2481 ,(2009) , 10.1016/J.JURO.2009.01.115
Surena F. Matin, Vitaly Margulis, Ashish Kamat, Christopher G. Wood, H. Barton Grossman, Gordon A. Brown, Colin P. N. Dinney, Randall Millikan, Arlene O. Siefker-Radtke, Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer. ,vol. 116, pp. 3127- 3134 ,(2010) , 10.1002/CNCR.25050